Consensus recommendations for systemic therapies in the management of relapsed Ewing sarcoma: A report from the National Ewing Sarcoma Tumor Board.
Cancer | 2024 | Gupta A, Dietz MS, Riedel RF, Dhir A
[Indexed for MEDLINE] 11. Lancet. 2022 Oct 29;400(10362):1513-1521. doi: 10.1016/S0140-6736(22)01790-1. Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial. Brennan B(1), Kirton L(2), Marec-Bérard P(3), Gaspar N(4), Laurence V(5), Martín-Broto J(6), Sastre A(7), Gelderblom H(8), Owens C(9), Fe...